NO980032L - Biologisk aktiv blanding omfattende cyklosporin - Google Patents

Biologisk aktiv blanding omfattende cyklosporin

Info

Publication number
NO980032L
NO980032L NO980032A NO980032A NO980032L NO 980032 L NO980032 L NO 980032L NO 980032 A NO980032 A NO 980032A NO 980032 A NO980032 A NO 980032A NO 980032 L NO980032 L NO 980032L
Authority
NO
Norway
Prior art keywords
cyclosporine
biologically active
phase
specific
active mixture
Prior art date
Application number
NO980032A
Other languages
English (en)
Norwegian (no)
Other versions
NO980032D0 (no
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of NO980032D0 publication Critical patent/NO980032D0/no
Publication of NO980032L publication Critical patent/NO980032L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO980032A 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin NO980032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
PCT/SE1996/000893 WO1997002042A1 (fr) 1995-07-06 1996-07-02 Composition biologiquement active contenant de la cyclosporine

Publications (2)

Publication Number Publication Date
NO980032D0 NO980032D0 (no) 1998-01-05
NO980032L true NO980032L (no) 1998-03-03

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980032A NO980032L (no) 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin

Country Status (12)

Country Link
EP (1) EP0873133B1 (fr)
JP (1) JPH11508592A (fr)
AT (1) ATE213951T1 (fr)
AU (1) AU6374596A (fr)
BR (1) BR9609332A (fr)
CA (1) CA2226219A1 (fr)
CZ (1) CZ1998A3 (fr)
DE (2) DE69619700T2 (fr)
ES (1) ES2123477T3 (fr)
NO (1) NO980032L (fr)
SE (1) SE504582C2 (fr)
WO (1) WO1997002042A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
WO1999029316A1 (fr) 1997-12-10 1999-06-17 Severson, Mary, L. Compositions pharmaceutiques contenant une huile d'acide gras omega-3
MXPA01005884A (es) * 1998-12-11 2002-04-24 Pharmasolutions Inc Composiciones auto-emulsionantes para medicamentos escasamente solubles en agua.
DE60221287T4 (de) 2001-11-08 2009-06-25 Atrium Medical Corp. Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
WO2006036984A2 (fr) 2004-09-28 2006-04-06 Atrium Medical Corporation Film autonome et procedes de fabrication d'un tel film
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (fr) 2005-10-15 2007-04-26 Atrium Medical Corporation Gels hydrophobes reticules pour revetements bioabsorbables de vecteur de medicament
EP2083875B1 (fr) 2006-11-06 2013-03-27 Atrium Medical Corporation Filet chirurgical enrobe
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
EP2471518B1 (fr) 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprenant des gouttes d'huile
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
WO2012009707A2 (fr) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
WO2016071515A1 (fr) * 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprenant de la cyclosporine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
SE504582C2 (sv) 1997-03-10
SE9502472L (sv) 1997-01-07
EP0873133A1 (fr) 1998-10-28
ATE213951T1 (de) 2002-03-15
ES2123477T3 (es) 2002-08-01
BR9609332A (pt) 1999-05-25
SE9502472D0 (sv) 1995-07-06
DE69619700T2 (de) 2002-10-24
JPH11508592A (ja) 1999-07-27
WO1997002042A1 (fr) 1997-01-23
EP0873133B1 (fr) 2002-03-06
CA2226219A1 (fr) 1997-01-23
ES2123477T1 (es) 1999-01-16
AU6374596A (en) 1997-02-05
CZ1998A3 (cs) 1998-06-17
DE873133T1 (de) 1999-05-06
NO980032D0 (no) 1998-01-05
DE69619700D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
NO980032L (no) Biologisk aktiv blanding omfattende cyklosporin
GB2305122B (en) Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
NO20005431D0 (no) Gelérbare farmasøytiske preparater
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DK312583D0 (da) Kortikoidholdigt praeparat til topisk applikation
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
IE873213L (en) Galenical Formulation
FI884291A (fi) Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi
SE8007639L (sv) Nya tabletter for upplosning i tjocktarmen samt sett for framstellning derav
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
FR2553409B1 (fr) Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
YU49113B (sh) Postupak za dobijanje klavulanat soli
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
IE36563L (en) Triazolo benzodiazepines
ES463092A1 (es) Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
ES8504665A1 (es) Metodo de preparar derivados de p-acilaminofenol
JPS54126722A (en) Slow release antibiotic tablet
JPS5558203A (en) Hard polyvinyl alcohol gel and its preparation
JPS5354866A (en) Method of treating sewege
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS5257392A (en) Immobilized enzyme using fibroin as carrier and method of preparing th e same
JPS5557510A (en) Preparation of improved oil foundation
FR2449450A1 (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
EP0482213A4 (en) Antineoplastic agent
JPS5799519A (en) Stable suppository and its preparation